Coverage begins July 1, 2026, for new and existing patients and will run through December 31, 2027
2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for metabolic and bariatric surgery
De, S., et al., Unraveling the Ties: Type 2 Diabetes and Parkinsons Disease - A Nano-Based Targeted Drug Delivery Approach
Ambulatory Blood Pressure Monitoring The effect of QSYMIA on blood pressure as measured by 24-hr ABPM was evaluated in a randomized, double-blind, 3-arm (QSYMIA, placebo, and active phentermine comparator) study of adults with obesity or overweight and at least one weight-related comorbidity
Mantovani G, Macci A, Madeddu C, Gramignano G, Serpe R, Massa E, et al